Research on prognostic factors in advanced pancreatic cancer treated by "Qingyi Huaji Formula"based on survival analysis
高惠峰,陈颢,冯兰云,王鹏,王琨,林钧华,陈震,孟志强,刘鲁明
DOI: https://doi.org/10.16305/j.1007-1334.2014.06.040
2014-01-01
Abstract:Objective To analyze the prognostic factors in patients with advanced pancreatic cancer treated by integrated Chinese and western medicine mainly withQingyi Huaji Formula,and to provide references for the treatment. Methods By historical prospective study method,we collected 454 advanced pancreatic cancer patients' clinical data retrospectively. SPSS 16. 0 was used to build database and life table method was used to calculate the survival rate of 1,2,3,and5 years. Kaplan-Meier method was used to calculate the survival and Log-rank test was used to compare the differences between two groups. A multifactorial Cox proportional hazard model analysis was introduced to examine the prognostic factor in patients with advanced pancreatic cancer. Results ①The median survival time of 454 patients with advanced pancreatic cancer was 6. 7 months. InQingyi Huaji Formulagroup,the median survival time was 7. 6 months and was 5. 4months in non-Qingyi Huaji Formulagroup,with significant differences between the two groups( P 0. 05). InQingyi Huaji Formulagroup,the survival rate of 1,2,3,and 5 years was 29. 60%,12. 46%,9. 35% and 5. 92% respectively. In the control group,the survival rate of 1,2,3,and 5 years was13. 53%,5. 26%,3. 01% and 0. 00% respectively,with significant differences between the two groups( P 0. 05). ② Single-factor analysis showed that liver metastases,KPS,CA19-9,GGT,glucose abnormal,ascites,pain,weight loss,QYHJ formula and pancreatic radiotherapy were prognostic factors( P 0. 20).③ Multi-factor analysis showed that liver metastases,KPS 80,CA19-9≥500 mg/L,GGT≥110 U/L,glucose abnormal,ascites,pain and weight loss≥10%were risk factors and QYHJ formula and pancreatic radiotherapy were independent protective factors. Conclusion ①Comparing with non-QYHJ formula,QYHJ formula has an advantage in prolonging survival of patients with advanced pancreatic cancer. ②QYHJ formula and pancreatic radiotherapy reduce the death risk of patients with advanced pancreatic cancer. Patients may benefit from them. ③The treatment with integrated western medicine and QYHJ Formula has an advantage in the patients with advanced pancreatic cancer. It is worth further promotion.